Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in Renal Cell Carcinoma Patients

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number142
Number of pages12
JournalFrontiers in cardiovascular medicine
Volume5
DOIs
Publication statusPublished - 16 Oct 2018

Keywords

  • platelets
  • thrombus
  • tyrosine kinase inhibitor
  • phosphatidylserine
  • pazopanib
  • procoagulant activity
  • THROMBUS FORMATION
  • IN-VIVO
  • GLYCOPROTEIN VI
  • CANCER-PATIENTS
  • KEY ROLE
  • ACTIVATION
  • COLLAGEN
  • SYK
  • RECEPTOR
  • INTEGRIN

Cite this